• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脂蛋白的分子成像磁共振造影剂用于早期动脉粥样硬化疾病无创检测的研发。

Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease.

作者信息

Mitsumori L M, Ricks J L, Rosenfeld M E, Schmiedl U P, Yuan C

机构信息

Department of Radiology and Pathobiology, University of Washington, Seattle, WA, USA.

出版信息

Int J Cardiovasc Imaging. 2004 Dec;20(6):561-7. doi: 10.1007/s10554-004-7020-4.

DOI:10.1007/s10554-004-7020-4
PMID:15856643
Abstract

INTRODUCTION

Currently there are no clinically available means of noninvasively detecting early atherosclerotic disease because these lesions are characterized by an accumulation of extracellular lipid and foam cells, but a lack of significant wall thickening or architectural distortion.

OBJECTIVE

We hypothesize that a paramagnetically labeled low density lipoprotein (LDL) could serve as a functional probe to detect sites of abnormal lipid metabolism in the vessel wall that represent sites of early disease.

METHODS

Isolated LDL was first incubated with manganese-mesoporphyrin, a hydrophobic MR contrast agent (MnMeso). Size exclusion chromatography and absorption mass spectroscopy were performed on the resulting samples to prove that an association between the two occurred. Subsequently, foam cell cultures (n=7) were incubated (10-30 microg/ml for 48 h) with these labeled lipoproteins and the T1 relaxivity of centrifuged pellets of these cells was determined by using an inversion recovery sequence on a 1.5T scanner. These results were compared to control measurements made from foam cell cultures fed unlabeled lipoproteins (n=7).

RESULTS

Measured T1 relaxation times of the cells fed the MnMeso-LDL (443.3 +/- 51.8 ms) was significantly different from the T1 relaxivity obtained from cells fed unlabeled lipoproteins (661.3 +/- 60.9 ms). These findings indicate that the amount of contrast bound to the constructed lipoproteins is sufficient to produce measurable MR signal changes noninvasively.

CONCLUSIONS

The study results support the feasibility of future in vivo MR experiments with labeled lipoproteins to assess lipoprotein kinetics in the vessel wall, which will hopefully provide a means of detecting early atherosclerotic disease.

摘要

引言

目前尚无临床上可用的非侵入性检测早期动脉粥样硬化疾病的方法,因为这些病变的特征是细胞外脂质和泡沫细胞的积累,但缺乏明显的管壁增厚或结构变形。

目的

我们假设顺磁性标记的低密度脂蛋白(LDL)可作为一种功能性探针,用于检测血管壁中代表早期疾病部位的异常脂质代谢位点。

方法

首先将分离的LDL与锰-中卟啉(一种疏水性磁共振造影剂,MnMeso)一起孵育。对所得样品进行尺寸排阻色谱和吸收质谱分析,以证明两者之间发生了结合。随后,将泡沫细胞培养物(n = 7)与这些标记的脂蛋白一起孵育(10 - 30μg/ml,共48小时),并使用1.5T扫描仪上的反转恢复序列测定这些细胞离心沉淀物的T1弛豫率。将这些结果与用未标记脂蛋白喂养的泡沫细胞培养物(n = 7)的对照测量结果进行比较。

结果

用MnMeso - LDL喂养的细胞测得的T1弛豫时间(443.3±51.8毫秒)与用未标记脂蛋白喂养的细胞获得的T1弛豫率(661.3±60.9毫秒)有显著差异。这些发现表明,与构建的脂蛋白结合的造影剂数量足以产生可测量的非侵入性磁共振信号变化。

结论

研究结果支持未来用标记脂蛋白进行体内磁共振实验以评估血管壁脂蛋白动力学的可行性,这有望提供一种检测早期动脉粥样硬化疾病的方法。

相似文献

1
Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease.基于脂蛋白的分子成像磁共振造影剂用于早期动脉粥样硬化疾病无创检测的研发。
Int J Cardiovasc Imaging. 2004 Dec;20(6):561-7. doi: 10.1007/s10554-004-7020-4.
2
Association with oleic acid vesicles enhances manganese III mesoporphyrin absorption and biliary elimination in rats.
Invest Radiol. 1999 Oct;34(10):615-20. doi: 10.1097/00004424-199910000-00002.
3
Foam cells in explants of atherosclerotic rabbit aortas have receptors for beta-very low density lipoproteins and modified low density lipoproteins.动脉粥样硬化兔主动脉外植体中的泡沫细胞具有β-极低密度脂蛋白和修饰的低密度脂蛋白的受体。
Arteriosclerosis. 1983 Jan-Feb;3(1):2-12. doi: 10.1161/01.atv.3.1.2.
4
Interaction of manganese-mesoporphyrin with oleic acid vesicles.
Biochemistry. 1995 Mar 14;34(10):3416-22. doi: 10.1021/bi00010a033.
5
Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation.与兔非病变主动脉内膜-中膜相比,动脉粥样硬化部位脂蛋白(a)的降解增加:脂蛋白(a)可能促进泡沫细胞形成的体内证据。
Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):641-9. doi: 10.1161/01.atv.18.4.641.
6
Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions.脂蛋白-蛋白聚糖复合物可诱导兔动脉粥样硬化病变泡沫细胞中胆固醇酯持续积累。
J Clin Invest. 1993 Mar;91(3):1011-8. doi: 10.1172/JCI116257.
7
Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.用于动脉粥样硬化成像的 MRI 造影剂 P947 的分子和细胞靶点。
Mol Pharm. 2012 Apr 2;9(4):850-61. doi: 10.1021/mp2003863. Epub 2012 Mar 8.
8
Vessel wall MRI of the thoracic aorta: correlation to histology and transesophageal ultrasound. Preliminary results.
Rofo. 2002 May;174(5):568-72. doi: 10.1055/s-2002-28272.
9
Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.兔动脉粥样硬化病变原代细胞培养中的脂蛋白降解与胆固醇酯化
Am J Pathol. 1990 Aug;137(2):457-65.
10
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.从兔动脉粥样硬化病变中新鲜分离出的巨噬细胞源性泡沫细胞可降解修饰的脂蛋白,促进低密度脂蛋白的氧化,并含有氧化特异性脂质-蛋白质加合物。
J Clin Invest. 1991 Jan;87(1):90-9. doi: 10.1172/JCI115006.

引用本文的文献

1
Lipoproteins and lipoprotein mimetics for imaging and drug delivery.用于成像和药物递送的脂蛋白及脂蛋白模拟物。
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):116-131. doi: 10.1016/j.addr.2016.04.020. Epub 2016 Apr 29.
2
Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.用于药物靶向和成像的脂蛋白相关及载脂蛋白介导的递送系统。
Curr Med Chem. 2015;22(31):3631-51. doi: 10.2174/0929867322666150716114625.
3
MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements.下肢外周动脉疾病的磁共振成像:最新进展

本文引用的文献

1
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.用于预测首次动脉粥样硬化血栓形成事件的既定和新兴血浆生物标志物。
Circulation. 2004 Jun 29;109(25 Suppl 1):IV6-19. doi: 10.1161/01.CIR.0000133444.17867.56.
2
The laboratory rabbit: an animal model of atherosclerosis research.实验用兔:动脉粥样硬化研究的动物模型。
Lab Anim. 2004 Jul;38(3):246-56. doi: 10.1258/002367704323133628.
3
Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging.通过钆弗罗胺增强的体内磁共振成像检测到富含脂质的动脉粥样硬化斑块。
Curr Cardiovasc Imaging Rep. 2013 Feb 1;6(1):55-60. doi: 10.1007/s12410-012-9175-z.
4
Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.用于血管和心脏疾病的纳米颗粒作为磁共振成像造影剂
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):146-161. doi: 10.1002/wnan.114. Epub 2010 Oct 21.
5
HDL as a contrast agent for medical imaging.高密度脂蛋白作为医学成像的造影剂。
Clin Lipidol. 2009 Aug;4(4):493-500. doi: 10.2217/clp.09.38.
6
Modified natural nanoparticles as contrast agents for medical imaging.改性天然纳米颗粒作为医学成像的对比剂。
Adv Drug Deliv Rev. 2010 Mar 8;62(3):329-38. doi: 10.1016/j.addr.2009.11.005. Epub 2009 Nov 6.
7
Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles.通过用负载钆的低密度脂蛋白颗粒靶向低密度脂蛋白受体进行磁共振成像检测肿瘤细胞。
Neoplasia. 2007 Dec;9(12):1046-56. doi: 10.1593/neo.07682.
8
Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage.使用靶向巨噬细胞的造影剂在动脉粥样硬化检测与特征分析方面的进展。
J Nucl Cardiol. 2006 Sep;13(5):699-709. doi: 10.1016/j.nuclcard.2006.07.004.
9
Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.作为磁共振成像造影剂的低密度脂蛋白纳米颗粒。
Neoplasia. 2006 Jun;8(6):488-98. doi: 10.1593/neo.05835.
10
Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.用于血管炎症磁共振成像的靶向巨噬细胞清道夫受体的造影剂的研发。
Bioconjug Chem. 2006 Mar-Apr;17(2):538-47. doi: 10.1021/bc060018k.
Circulation. 2004 Jun 15;109(23):2890-6. doi: 10.1161/01.CIR.0000129310.17277.E7. Epub 2004 Jun 7.
4
Subclinical atherosclerosis as a target of therapy: potential role of statins.亚临床动脉粥样硬化作为治疗靶点:他汀类药物的潜在作用
Am J Cardiol. 2004 Mar 15;93(6):737-40. doi: 10.1016/j.amjcard.2003.11.072.
5
Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.超小超顺磁性氧化铁对高脂血症兔动脉粥样硬化斑块的磁共振成像
Circulation. 2001 Jan 23;103(3):415-22. doi: 10.1161/01.cir.103.3.415.
6
Molecular imaging: exploring the next frontier.
Radiology. 1999 Sep;212(3):609-14. doi: 10.1148/radiology.212.3.r99se18609.
7
Aggregation and fusion of modified low density lipoprotein.
J Lipid Res. 1996 Dec;37(12):2638-49.
8
Residence time of low-density lipoprotein in the normal and atherosclerotic rabbit aorta.
Circ Res. 1997 Feb;80(2):208-18. doi: 10.1161/01.res.80.2.208.
9
Potential of 99mTc-LDLs labeled by two different methods for scintigraphic detection of experimental atherosclerosis in rabbits.
Arterioscler Thromb. 1993 Jan;13(1):78-83. doi: 10.1161/01.atv.13.1.78.
10
Pharmaceutical properties, biodistribution, and imaging characteristics of manganese-mesoporphyrin. A potential hepatobiliary contrast agent for magnetic resonance imaging.
Invest Radiol. 1993 Oct;28(10):925-32. doi: 10.1097/00004424-199310000-00013.